Market Size (2016)
2016
$580.97M
Vertical: HealthcareBase Year: 201811 Sections
Market Size (2016)
2016
$580.97M
Projected (2025)
2025
$973.94M
CAGR (2016–2025)
5.9%
5.9%Key Players
107+
Hemorrhoids, also called piles, are swollen and inflamed blood vessels in the anus as well as in the lower rectum. The patient suffers from painless bleeding at the time of bowel movement, itching or irritation in the anal region, and swelling around the anus. Hemorrhoid is of two types, namely, internal and external hemorrhoid. Hemorrhoid treatment includes changing the diet to avoid constipation to prevent further irritation, use of topical medication, and surgery at times if required. Hemorrhoid treatment devices reduce procedure time and also provides easy access to the target site for optimal patient comfort.
The Hemorrhoid Treatment Devices Market market is projected to grow at a CAGR of 5.9% from 2016 to 2025.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansHemorrhoids, also called piles, are swollen and inflamed blood vessels in the anus as well as in the lower rectum. The patient suffers from painless bleeding at the time of bowel movement, itching or irritation in the anal region, and swelling around the anus. Hemorrhoid is of two types, namely, internal and external hemorrhoid. Hemorrhoid treatment includes changing the diet to avoid constipation to prevent further irritation, use of topical medication, and surgery at times if required. Hemorrhoid treatment devices reduce procedure time and also provides easy access to the target site for optimal patient comfort.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2018
Historical Period
2016 – 2018
Forecast Period
2018 – 2025
Primary Interviews
150+
Historical data (2016–2018) and forecast period (2018–2025)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThreat of New Entrants
The threat of new entrants is moderate in the global hemorrhoid treatment devices market due to the development of the potential market. Any company trying to enter the market is required to accept and abide by the mandatory regulatory standards. This market is also characterized by a reasonable degree of brand loyalty, where establishing a brand name is difficult for new entrants. The rising awareness regarding hemorrhoid treatment among the patient pool pushes the currently established and other manufacturers to focus more on developing products with the incorporation of innovation. There is a stronghold of the big companies in this market, which can make the entry of the new players challenging. Thus, the threat of new entrants in the market is moderate.
Bargaining Power of Suppliers
In the global hemorrhoid treatment devices industry, suppliers are device manufacturers. The existing key companies capture a significant share of the market and have the capability of influencing the cost of the products. Another factor affecting the bargaining power of suppliers is the switching cost for buyers. Furthermore, many companies are focused on entering the developing economies, which increases competition in the market. Therefore, the overall bargaining power of suppliers in the global hemorrhoid treatment devices market is moderate.
Threat of Substitutes
The threat of substitutes in the global hemorrhoid treatment devices market is moderate to high. Substitutes pose a moderate to high threat in the global hemorrhoid treatment devices market due to the availability of different types of similar products by the key market players. However, quality and trust issues for the products provided by the new players, and excellent service provided by the existing players may restrict the threat by the substitutes to an extent.
Bargaining Power of Buyers
The bargaining power of buyers is low to moderate in the global hemorrhoid treatment devices market. Hospitals and clinics are the primary buyers in the market. The presence of buyers in the market is growing due to the increasing awareness about the different products, along with the rising number of people suffering from hemorrhoids. Also, some buyers are price and brand sensitive and might prefer particular products from certain companies, thereby moderately affecting their bargaining power in the market.
Intensity of Rivalry
The degree of competition in the global hemorrhoid treatment devices market is moderate to high. The moderate degree of product differentiation among existing players increases the intensity of rivalry in the market. Companies involved in the global hemorrhoid treatment devices industry are trying to develop different types of devices to make product differentiation more affordable. To overcome the competition, players are engaged in developing a process to lower their manufacturing costs. Moreover, the players are also developing advanced techniques for differentiating their product from their rivals.
Market estimates by geography (2025)
InsightAmericas leads with $435.49M by 2025.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2016 | 2018 | 2025 | CAGR | SHARE |
|---|---|---|---|---|---|
| Middle East and Africa | $35.96M | $47.54M | $55.17M | 4.9% | 6% |
| Americas | $253.07M | $334.72M | $435.49M | 6.2% | 45% |
| Asia Pacific | $102.25M | $137.82M | $170.89M | 5.9% | 18% |
| Europe | $189.69M | $253.36M | $312.39M | 5.7% | 32% |
| Total | $580.97M | $773.44M | $973.94M | 5.9% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$973.94M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Rubber Band Ligators | $338.29M | 5.9% | 85% |
| Infrared Coagulators | $176.13M | 5.9% | 85% |
| Proctoscopes | $143.37M | 5.9% | 66% |
| Anoscopes | $122.64M | 5.9% | 60% |
| Doppler Probes | $100.46M | 5.9% | 89% |
| Cryotherapy Devices | $42.84M | 5.9% | 47% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Hemorrhoid Treatment Devices Market covering market dynamics, competitive landscape, and strategic outlook.
The Hemorrhoid Treatment Devices Market market is projected to reach $973.94M by 2025, growing at 5.9% CAGR. The Rubber Band Ligators segment holds the largest share.
Hemorrhoids are also known as piles. These are swollen veins in the lower part of the rectum and anus. As hemorrhoids generally get worse over time, doctors suggest that they should be treated immediately. Hemorrhoids occur when the veins surrounding the anus are enlarged. Women are more likely to get hemorrhoids in pregnancy, and it could develop with increasing age. Hemorrhoid treatment devices are used to apply controlled, conductive heating to hemorrhoids, which are intended to provide temporary relief.
The growth of the global hemorrhoid treatment devices market is attributed to rising cases of hemorrhoids and a rise in number of hemorrhoids surgery. Also, the rising prevalence of chronic diarrhea or constipation is anticipated to fuel the growth of the global hemorrhoid treatment devices market.
However, most experienced surgeons are preferring nonoperative therapies and relying less on operative hemorrhoidectomy, thus restraining the growth of the market.
Hemorrhoid is a swelling in the anal canal or around the anus with an enlarged blood vessel inside it. Straining during bowel movements, having chronic constipation or diarrhea, pregnancy, and obesity leads to an increase in incidences of hemorrhoids. The growing number of cases of hemorrhoids is pushing the demand for hemorrhoid treatment devices, which attributes to the growth of the hemorrhoid treatment devices market globally.
For instance, the National Center for Biotechnology Information stated that hemorrhoid is the fourth leading outpatient gastrointestinal diagnosis that accounts for ∼3.3 million ambulatory care visits in the US. Self-reported incidences of hemorrhoids in the US are 10 million each year, which is around 4.4% of the population.
According to the International Surgery Journal, 2018, hemorrhoid is one of the common diseases observed in patients below age 40, especially when they are under stress.
Additionally, the National Institute of Diabetes and Digestive and Kidney Diseases stated that hemorrhoids are common in both women and men and affects about 1 in 20 people in the Americas. Also, about half of the adult population aged 50 years or more have hemorrhoids. Thus, the growing cases of hemorrhoids are expected to be the driving factor for the hemorrhoid treatment devices market.
The available hemorrhoid treatment devices are reliable and also help to reduce several complications of patients, including pain. They also normalize the routine activities of patients. Despite advances in office-based procedures and better surgical approaches available, many challenges remain same such as disease recurrence and post-procedural pain.
Researchers are focusing on the development of novel treatment methods and devices so that they can minimize pain after the procedure and prevent recurrent hemorrhoids.
For example, in March 2019, De Scalene launched ‘Cryocure”, a new and affordable device to treat hemorrhoids without surgery. Cryocure helps to stop bleeding from anal blood vessels and constriction of those blood vessels.
Moreover, increasing the participation of players in the field of hemorrhoids treatment is driving the growth of the hemorrhoid treatment device market.
Privi Medical, one of the players operating in the hemorrhoid treatment devices market, has received FDA clearance for its “Instalief’ hemorrhoids treatment device. The disposable device features an advanced “instant cold compression technology” to treat hemorrhoids.
The rising need for novel therapies and the development of hemorrhoid treatment devices are, in turn, creating opportunities for hemorrhoid treatment devices market.
The product recall is the major challenge that is expected to hinder the growth of the market during the assessment period. Many devices used for the treatment of hemorrhoids are withdrawn by market players due to different issues.
For example, in April 2018, Covidien LLC recalled the end-to-end anastomosis (EEA) hemorrhoid and prolapse stapler set with DST Series Technology (instrument), which is designed for use as a stapler instrument for control of rectal prolapse and hemorrhoid disease.
Similarly, in December 2016, Ultroid Technologies, Inc. recalled Ultroid Hemorrhoid Management Systems 110/220 VAC and procedures kit, including the Ultroid Disposable Sterile Probes.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 107 companies operating in the Hemorrhoid Treatment Devices Market market, including revenue, employee count, and market positioning where available.
Showing 107 of 107 companies
CONMED Corporation
Company Headquarters: US Founded: 1970 Workforce: 4,500 Company Working: CONMED Corporation is a global medical technology company that provides surgical devices and equipment for minimally invasive procedures. CONMED operates in several segments including Orthopedic Surgery, General Surgery, Gastroenterology, Pulmonology, and Cardiology. One of the products offered by CONMED is the biopsy device, which is used for obtaining tissue samples from the body for diagnostic purposes. Biopsy devices are used in various medical specialties including gastroenterology, urology, pulmonology, and oncology. CONMED offers a range of biopsy devices including disposable and reusable forceps, needles, and brush biopsy instruments. These devices are designed to provide accurate and efficient tissue sampling with minimal patient discomfort. CONMED has a global workforce of above 4,000 employees, with operations in over 20 countries. The company has manufacturing facilities in the United States, Mexico, Costa Rica, France, and the United Kingdom.
OBP Medical Corporation
Company Headquarters: Massachusetts, US Founded: 2007 Workforce: ~11-50 Company Working: OBP Medical Corporation is a global medical device company that is reinventing the everyday tools wherein the providers rely on integrating single-use LED lighting technology into single-use devices. The company focuses on developing products that help to facilitate the transition of minimally invasive procedures. It has products that are in use at more than 10,000 physician offices, hospitals, and surgery centers all over the US. It has a rapidly expanding portfolio that offers a wide range of single-use, self-contained, illuminating products available in the market.
Sklar Surgical Instruments
Company Headquarters: Pennsylvania, US Founded: 1892 Workforce: ~51-200 Company Working: Sklar Surgical Instruments (Sklar) is a global provider of medical devices. It manufactures and distributes surgical instruments. The company has a wide portfolio of over 19,000 products that includes surgical instruments, instrument sets, patient safety, custom sterile procedure trays, and cleaning and disinfectant products. Additionally, the company has various products for orthopedic, dental, cardiovascular, endoscopic, dermatology, and veterinary markets. It also maintains a full warehouse of in-stock instruments and supplies that are ready for same-day shipment.
Integra LifeSciences Corporation
Company Headquarters: New Jersey, US Founded: 1989 Workforce: ~4,500 Company Working: Integra LifeSciences Holdings Corporation (Integra) is a world leader in medical technology. It offers innovative solutions for orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive & general surgery. Integra offers a broad portfolio of brands that include AmnioExcel, Bactiseal, Cadence, Certas, Codman, CUSA, DuraGen, DuraSeal, ICP Express, Integra, MediHoney, MicroFrance, PriMatrix, Salto Talaris, SurgiMend, TCC-EZ, Titan, and VersaTru. It sells its products through two business segments, namely, Codman specialty surgical and orthopedics and tissue technologies. It recently acquired one of the leading players of the global amniotic membrane market, Derma Sciences Inc. (US), a tissue regeneration company. Integra provides its innovative healthcare solutions in over 130 countries through more than 50 offices and worldwide distribution networks.
Privi Medical
Company Headquarters: Singapore Founded: 2014 Workforce: ~21 Company Working: Privi Medical (Privi) is an innovation-driven medical technology company turned out of the Stanford Byers Center for Biodesign and the Singapore-Stanford Biodesign programs and received support from Exploit Technologies (ETPL), the commercialization arm of the Agency for Science Technology & Research. The company developed a disposable product that provides immediate relief to people suffering from hemorrhoids. It has a drug-free product, named Instalief, which provides sufferers immediate relief without drug-related side-effects, and also improves the lives of millions of hemorrhoid sufferers globally.
Cook Medical
Company Headquarters: Bloomington, US Founded: 1963 Workforce: 12,000 + Company Working: Cook Medical is a global healthcare company engaged in developing, manufacturing, and distributing minimally invasive medical devices for diagnostic and therapeutic procedures. Other medical offerings of the company include urological and gynecological devices, biological materials, endoscopic accessories, cardiac rhythm management, and vascular products. Cook medical operates as a subsidiary of Cook Group Incorporated. It provides products and services related to anesthesiology, bariatrics, burn surgery, pediatric, peripheral cardiology, plastic surgery, reconstructive surgery, surgery, surgical endoscopy, endourology, and obstetrics. It is present in more than 135 countries.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Hemorrhoid Treatment Devices Market